Summary
Prion diseases (spongiform encephalopathies) in humans are Creutzfeldt-Jakob disease (CJD), Gerstmann-Sträussler-Scheinker syndrome (GSS), and kuru. Clinically, they are characterized by an inexorably progressing neurological illness with dementia and ataxia as the most prominent signs. The classical neuropathological changes are limited to the central nervous system and consist of spongiform degeneration, amyloid plaques, astrocytic gliosis, and nerve cell loss. The human spongiform encephalopathies, which for many years were considered neurodegenerative disorders of unknown etiology, were finally recognized as transmissible diseases similar to scrapie in sheep in the late 1960’s. The infectious agent appears to consist of protein devoid of functional nucleic acid and has been termed prion to distinguish it from viruses. The prion hypothesis has gained wide acceptance through the finding that mutations of the prion protein gene are associated with heritable human prion disease. Different mutations appear to cause prion disease with a distinct pattern of clinical and pathological features in a great number of families. Certain mutations of the PrP gene have been shown to be associated with clinical and neuropathological changes not typical of any variant of human prion disease known to date. A new classification of prion diseases based on the molecular biology and biochemistry of the prion protein is likely to emerge.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aiken JM, Marsh RF (1990) The search for scrapie agent nucleic acid. Microbiol Rev 54: 242–246
Alter M, Kahana E (1976) Creutzfeldt-Jakob disease among Libyan Jews in Israel. Science 192: 428
Araya G, Gâlvez S, Cartier L, Gajdusek DC (1983) A spatiotemporal clustering of Creutzfeldt-Jakob disease in Chile. Rev Chil Neuropsiquiat 21: 291–295
Arendt T, Bigl V, Arendt A (1984) Neurone loss in the nucleus basalis of Meynert in Creutzfeldt-Jakob disease. Acta Neuropathol 65: 85–88
Ball MJ (1980) Features of Creutzfeldt-Jakob disease in brains of patients with familial dementia of Alzheimer type. Can J Neurol Sci 7: 51–57
Basler K, Oesch B, Scott M, Westaway D, Wälchli M, Groth DF, McKinley MP, Prusiner SB, Weissmann C (1986) Scrapie and cellular PrP isoforms are encoded by the same chromosomal gene. Cell 46: 417–428
Beck E, Daniel PM (1987) Neuropathology of transmissible spongiform encephalopathy. In: Pruisner SB, McKinley MP (eds) Prions: novel infectious pathogens causing scrapie and Creutzfeldt-Jakob disease. Academic Press, New York, pp 331–385
Bendheim PE, Barry RA, DeArmond SJ, Stites DP, Prusiner SB (1984) Antibodies to a scrapie prion protein. Nature 310: 418–421
Bernoulli C, Siegfried J, Baumgartner G, Regli F, Rabinowicz T, Gajdusek DC, Gibbs Jr CJ (1977) Danger of accidental person-to-person transmission of Creutzfeldt-Jakob disease by surgery. Lancet 1: 478–479
Bobowick AR, Brody JA, Matthews MR, Roos R, Gajdusek DC (1973) CreutzfeldtJakob disease: a case-control study. Am J Epidemiol 98: 381–394
Bockman JM, Kingsbury DT, McKinley MP, Bendheim PE, Prusiner SB (1985) Creutzfeldt-Jakob disease prion proteins in human brains. N Engl J Med 312: 73–78
Brown P (1980) An epidemiologic critique of Creutzfeldt-Jakob disease. Epidemiol Rev 2: 113–135
Brown P (1989) Central nervous system amyloidoses: a comparison of Alzheimer’s disease and Creutzfeldt-Jakob disease. Neurology 39: 1103–1105
Brown P (1990) latrogenic Creutzfeldt-Jakob disease. Aust NZ J Med 20: 633–635
Brown P (1992) The phenotypic expression of different mutations in transmissible human spongiform encephalopathy. Rev Neurol (Paris) 148: 317–327
Brown P, Cathala F, Castaigne P, Gajdusek DC (1986) Creutzfeldt-Jakob disease: clinical analysis of a consecutive series of 230 neuropathologically verified cases. Ann Neurol 20: 597–602
Brown P, Cathala F, Sadowsky D, Gajdusek DC (1979) Creutzfeldt-Jakob disease in France: II. Clinical characteristics of 124 consecutive verified cases during the decade 1968–1977. Ann Neurol 6: 430–437
Brown P, Gajdusek DC, Gibbs Jr CJ, Asher DM (1985) Potential epidemic of Creutzfeldt-Jakob disease from human growth hormone therapy. N Engl J Med 313: 728–731
Brown P, Goldfarb LG, Kovanen J, Haltia M, Cathala F, Sulima M, Gibbs Jr CJ, Gajdusek DC (1992) Phenotypic characteristics of familial Creutzfeldt-Jakob disease associated with the codon 178Asn PRPNP mutation. Ann Neurol 31: 282–285
Brown P, Goldfarb LG, McCombie WR, Nieto A, Squillacote D, Sheremata W, Little BW, Godec MS, Gibbs Jr CJ, Gajdusek DC (1992) Atypical CreutzfeldtJakob disease in an American family with an insert mutation in the PRNP amyloid precursor gene. Neurology 42: 422–427
Brown P, Jannotta F, Gibbs Jr CJ, Baron H, Guiroy DC, Gajdusek DC (1990) Coexistence of Creutzfeldt-Jakob disease and Alzheimer’s disease in the same patient. Neurology 40: 226–228
Brown P, Rohwer RG, Gajdusek DC (1984) Sodium hydroxide decontamination of Creutzfeldt-Jakob disease virus. N Engl J Med 310: 727
Brown P, Wolff A, Gajdusek DC (1990) A simple and effective method for inactivating virus infectivity in formalin-fixed tissue samples from patients with Creutzfeldt-Jakob disease. Neurology 40: 887–890
Bruce ME, Dickinson AG (1987) Biological evidence that scrapie agent has an independent genome. J Gen Virol 68: 79–89
Bruce ME, McConnell I, Fraser H, Dickinson AG (1991) The disease characteristics of different strains of scrapie in sinc congenic mouse lines. Complications for the nature of the agent and host control of pathogenesis. J Gen Virol 72: 595–604
Buchanan CR, Preece MA, Milner RDG (1991) Mortality, neoplasia, and Creutzfeldt-Jakob disease in patients treated with human pituitary growth hormone in the United Kingdom. Br Med J 302: 824–828
Bugiani O, Tagliavini F, Giaconne G, Boeri R (1989) Creutzfeldt-Jakob disease: astrocytosis and spongiform changes of the white matter. In: Court LA, Dormont D, Brown P, Kingsburg DT (eds) Unconventional virus disease of the central nervous system. Département de Protection Sanitaire, Fonteney-aux-Roses Cedex, pp 172–183
Büeler H, Fischer M, Lang Y, Bluethmann H, Lipp H-P, DeArmond SJ, Prusiner SB, Aguet M, Weissmann C (1992) Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature 356: 577–582
Cathala F, Baron H (1987) Clinical aspects of Creutzfeldt-Jakob disease. In: Prusiner SB, McKinley MP (eds) Prions: novel infectious pathogens causing scrapie and Creutzfeldt-Jakob disease. Academic Press, New York, pp 467–509
Chou SM, Payne WN, Gibbs Jr CJ, Gajdusek DC (1980) Transmission and scanning electron microscopy of spongiform change in Creutzfeldt-Jakob disease. Brain 103: 885–904
Clinton J, Lantos PL, Rossor M, Mullan M, Roberts GW (1990) Immunocytochemical confirmation of prion protein. Lancet 336: 515
Cochius JI, Mack K, Burns RJ, Alderman CP; Blumbergs PC (1990) CreutzfeldtJakob disease in a recipient of human pituitary-derived gonadotrophin. Aust NZ J Med 20: 592–593
Collinge J, Harding AE, Owen F, Poulter M, Lofthouse R, Boughey AM, Shah T, Crow TJ (1989) Diagnosis of Gerstmann-Sträussler syndrome in familial dementia with prion protein gene analysis. Lancet 2: 15–17
Collinge J, Owen F, Poulter M, Leach M, Crow TJ, Rossor MN, Hardy J, Mullan MJ, Janota I, Lantos PL (1990) Prion dementia without characteristic pathology. Lancet 336: 7–9
Collinge J, Palmer MS, Dryden AJ (1991) Genetic predisposition to iatrogenic Creutzfeldt-Jakob disease. Lancet 337: 1441–1442
Connolly JH, Allen IV, Dermott E (1988) Transmissible agent in the amyotrophic form of Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 51: 1459–1460
Creutzfeldt HG (1920) Über eine eigenartige herdförmige Erkrankung des Zentralnervensystems. Z Ges Neurol Psychiatr 57: 1–18
Croxson M, Brown P, Synek B, Harrington MG, Frith R, Clover G, Wilson J, Gajdusek DC (1988) A new case of Creutzfeldt-Jakob disease associated with human growth hormone therapy in New Zealand. Neurology 38: 1128–1130
Cuillé J, Chelle PL (1936) Pathologie animale-La maladie dite tremblante du mouton est-elle inoculable? C R Acad Sci (III) 203: 1552–1554
Daniel PM (1972) Creutzfeldt-Jakob disease. J Clin Pathol Suppl (R Coll Pathol) 6: 97–101
Davanipour Z, Goodman L, Alter M, Sobel E, Asher D, Gajdusek DC (1984) Possible modes of transmission of Creutzfeldt-Jakob disease. N Engl J Med 311: 1582–1583
DeArmond SJ, Mobley WC, DeMott DL, Barry RA, Beckstead JH, Prusiner SB (1987) Changes in the localization of brain prion proteins during scrapie infection. Neurology 37: 1271–1280
Devillemeur TB, Gourmelen M, Beauvais P, Rodriguez D, Vaudour G, Deslys JP, Dormont D, Richard P, Richardet J-M (1992) Maladie de Creutzfeldt-Jakob chez quatre enfants traités par hormone de croissance. Rev Neurol (Paris) 148: 328–334
Diedrich JF, Minnigan H, Carp RI, Whitaker JN, Race R, Frey II W, Haase AT (1991) Neuropathological changes in scrapie and Alzheimer’s disease are associated with increased expression of apolipoprotein E and cathepsin D in astrocytes. J Virol 65: 4759–4768
Doh-ura K, Tateishi J, Sasaki H, Kitamoto T, Sakaki Y (1989) Pro — Leu change at position 102 of prion protein is the most common but not the sole mutation related to Gerstmann-Sträussler syndrome. Biochem Biophys Res Commun 163: 974–979
Duffy P, Wolf J, Collins G, DeVoe AG, Streeten B, Cowen D (1974) Possible person-to-person transmission of Creutzfeldt-Jakob disease. N Engl J Med 290: 692–693
Duguid JR, Dinauer MC (1990) Library subtraction of in vitro cDNA libraries to identify differentially expressed genes in scrapie infection. Nucleic Acids Res 18: 2789–2792
Duguid JR, Rohwer RG, Seed B (1988) Isolation of cDNAs of scrapie-modulated RNAs by subtractive hybridization of a cDNA library. Proc Natl Acad Sci USA 85: 5738–5742
Ferber RA, Wiesenfeld SL, Roos RP, Bobowick AR, Gibbs Jr CJ, Gajdusek DC (1974) Familial Creutzfeldt-Jakob disease: transmission of the familial disease to primates. In: Subirana A, Burrows JM (eds) Proceedings of the Xth International Congress of Neurology. Excerpta Medica, ICS No. 319, Amsterdam, pp 358–380
Flament-Durand J, Couck AM (1979) Spongiform alterations in brain biopsies of presenile dementia. Acta Neuropathol (Berl) 46: 159–162
Fradkin JE, Schonberger LB, Mills JL, Gunn WJ, Piper JM, Wysowski DK, Thomson R, Durako S, Brown P (1991) Creutzfeldt-Jakob disease in pituitary growth hormone recipients in the United States. JAMA 265: 880–884
Gajdusek DC, Gibbs CJ, Alpers M (1966) Experimental transmission of a kurulike syndrome to chimpanzees. Nature 209: 794–796
Gajdusek DC, Zigas V (1957) Degenerative disease of the central nervous system in New Guinea. The endemic occurrence of “kuru” in the native population. N Engl J Med 257: 974–978
Gerstmann J (1928) Über ein noch nicht beschriebenes Reflexphänomen bei einer Erkrankung des zerebellären Systems. Wien Med Wochenschr 78: 906–908
Gerstmann J, Sträussler E, Scheinker I (1936) Über eine eigenartige hereditär-familiäre Erkrankung des Zentralnervensystems. Zugleich ein Beitrag zur Frage des vorzeitigen lokalen Alterns. Z Neurol 154: 736–762
Ghetti B, Tagliavini F, Masters CL, Beyreuther K, Giaccone G, Verga L, Farlow MR, Conneally PM, Dlouhy SR, Azzarelli B, Bugiani O (1989) GerstmannSträussler-Scheinker disease. II. Neurofibrillary tangles and plaques with PrPamyloid coexist in an affected family. Neurology 39: 1453–1461
Gibbs CJ Jr, Amyx HL, Bacote A, Masters CL, Gajdusek DC (1980) Oral transmission of kuru, Creutzfeldt-Jakob disease, and scrapie to nonhuman primates. J Infect Dis 142: 205–208
Gibbs CJ Jr, Gajdusek DC, Asher DM, Alpers MP, Beck E, Daniel PM, Matthews WP (1968) Creutzfeldt-Jakob disease (spongiform encephalopathy): transmission to the chimpanzee. Science 161: 388–389
Gibbs CJ Jr, Joy A, Heffner R, Franko M, Miyazaki M, Asher DM, Parisi JE, Brown PW, Gajdusek DC (1985) Clinical and pathological features and laboratory confirmation of Creutzfeldt-Jakob disease in a recipient of pituitary-derived human growth hormone. N Engl J Med 313: 734–738
Goldfarb LG, Brown P, Goldgaber D, Asher DM, Strass N, Graupera G, Piccardo P, Brown WT, Rubinstein R, Boellaard JW, Gajdusek DC (1989) Patients with Creutzfeldt-Jakob disease and kuru lack the mutation in the PRIP gene found in Gerstmann-Sträussler syndrome, but they show a different double allele mutation in the same gene. Am J Hum Genet 45 [Suppl]: A189 (Abstract)
Goldfarb LG, Brown P, Haltia M, Cathala F, McCombie WR, Kovanen J, Cervenâkovâ L, Goldin L, Nieto A, Godec MS, Asher DM, Gajdusek DC (1992) Creutzfeldt-Jakob disease cosegregates with the condon 178Asn PRNP mutation in families of European origin. Ann Neurol 31: 274–281
Goldfarb LG, Brown P, McCombie WR, Goldgaber D, Swergold GD, Wills PR, Cervenakova L, Baron H, Gibbs Jr CJ, Gajdusek DC (1991) Transmissible familial Creutzfeldt-Jakob disease associated with five, seven, and eight extra octapeptide coding repeats in the PRNP gene. Proc Natl Acad Sci USA 88: 10926–10930
Goldfarb LG, Brown P, Vrbovskâ A, Baron H, McCombie WR, Cathala F, Gibbs Jr CJ, Gajdusek DC (1992) An insert mutation in the chromosome 20 amyloid precursor gene in a Gerstmann-Sträussler-Scheinker family. J Neurol Sci 111: 189–194
Goldfarb LG, Korczyn AD, Brown P, Chapman J, Gajdusek DM (1990) Mutation in codon 200 of scrapie amyloid precursor gene linked to Creutzfeldt-Jakob disease in Sephardic Jews of Libyan and non-Libyan origin. Lancet 336: 637–638
Goldfarb LG, Mitrovâ E, Brown P, Toh BH, Gajdusek DC (1990) Mutation in codon 200 of scrapie amyloid protein gene in two clusters of Creutzfeldt-Jakob disease in Slovakia. Lancet 336: 514–515
Goldgaber D, Goldfarb LG, Brown P, Asher DM, Brown WT, Lin S, Teener JW, Feinstone SM, Rubenstein R, Kascsak RJ, Boellaard JW, Gajdusek DC (1989) Mutations in familial Creutzfeldt-Jakob disease and Gerstmann-SträusslerScheinker’s syndrome. Exp Neurol 106: 204–206
Gordon WS (1946) Advances in veterinary research. Looping-ill, tickborne fever and scrapie. Vet Res 58: 516–525
Gray EG (1986) Spongiform encephalopathy: a neurocytologist’s viewpoint with a note on Alzheimer’s disease. Ncuropathol. Appl Neurobiol 12: 149–172
Hadlow WJ (1959) Scrapie and kuru. Lancet 2: 289–290
Haltia M, Kovanen J, Goldfarb LG, Brown P, Gajdusek DC (1991) Familial Creutzfeldt-Jakob disease in Finland: epidemiological, clinical, pathological and molecular genetic studies. Eur J Epidemiol 7: 494–500
Harrington MG, Merril CR, Asher DM, Gajdusek DC (1986) Abnormal proteins in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. N Engl J Med 315: 279–283
Hecker R, Taraboulos A, Scott M, Pan K-M, Yang S-L, Torchia M, Jendroska K, DeArmond SJ, Prusiner SB (1992) Replication of distinct scrapie prion isolates is region specific in brains of transgenic mice and hamsters. Genes Dev 6: 1213–1228
Hirano A, Ghatak NR, Johnson AB, Partnow MJ, Gomori AJ (1972) Argentophilic plaques in Creutzfeldt-Jakob disease. Arch Neurol 26: 530–542
Hsiao K, Baker HF, Crow TJ, Poulter M, Owen F, Terwilliger JD, Westaway D, Ott J, Prusiner SB (1989) Linkage of a prion protein missense variant to Gerstmann-Sträussler syndrome. Nature 338: 342–345
Hsiao K, Dlouhy SR, Farlow MR, Cass C, Da Costa M, Conneally PM, Hodes ME, Ghetti B, Prusiner SB (1992) Mutant prion proteins in Gerstmann-SträusslerScheinker disease with neurofibrillary tangles. Nat Genet 1: 68–71
Hsiao K, Prusiner SB (1990) Inherited human prion diseases. Neurology 40: 1820–1827
Hsiao KK, Cass C, Schellenberg GD, Bird T, Devine-Gage E, Wisniewski H, Prusiner SB (1991) A prion protein variant in a family with the telencephalic form of Gerstmann-Sträussler-Scheinker syndrome. Neurology 41: 681–684
Hsiao KK, Cass C, Schellenberg G, Dwine-Gage E, Bird T, Prusiner SB (1990) Correlation of specific prion protein mutations with different forms of prion diseases. Neurology 40 [Suppl It 388 (Abstract)
Hsiao KK, Scott M, Foster D, Groth DF, DeArmond SJ, Prusiner SB (1990) Spontaneous neurodegeneration in transgenic mice with mutant prion protein. Science 250: 1587–1590
Jakob A (1921) Über eigenartige Erkrankungen des Zentralnervensystems mit bemerkenswertem anatomischem Befunde (spastische Pseudosklerose-Encephalomyelopathie mit disseminierten Degenerationsherden). Dtsch Z Nervenheilkd 70: 132–146
Jakob A (1923) Spastische Pseudosklerose. In: Jakob A (ed) Die extrapyramidalen Erkrankungen. Springer, Berlin Heidelberg, pp 215–245
Kim JH, Manuelidis EE (1989) Neuronal alterations in experimental CreutzfeldtJakob disease: a Golgi study. J Neurol Sci 89: 93–101
Kimberlin RH (1990) Bovine spongiform encephalopathy. Taking stock of the issues. Nature 345: 763–764
Kimberlin RH, Walker CA, Fraser H (1989) The genomic identity of different strains of mouse scrapie is expressed in hamsters and preserved on reisolation in mice. J Gen Virol 70: 2017–2026
Kirschbaum WR (1968) Jakob-Creutzfeldt disease. Elsevier, New York
Kitamoto T, Muramoto T, Mohri S, Doh-ura K, Tateishi J (1991) Abnormal isoform of prion protein accumulates in follicular dendritic cells in mice with Creutzfeldt-Jakob disease. J Virol 65: 6292–6295
Kitamoto T, Ogomori K, Tateishi J, Prusiner SB (1987) Formic acid pretreatment enhances immunostaining of cerebral and systemic amyloids. Lab Invest 57: 230–236
Kitamoto T, Shin R-W, Doh-ura K, Tomokane N, Miyazono M, Muramoto T, Tateishi J (1992) Abnormal isoform of prion proteins accumulates in the synaptic structures of the central nervous system in patients with Creutzfeldt-Jakob disease. Am J Pathol 140: 1285–1294
Kitamoto T, Tateishi J (1988) Immunohistochemical confirmation of CreutzfeldtJakob disease with a long clinical course with amyloid plaque core antibodies. Am J Pathol 131: 435–443
Kitamoto T, Tateishi J, Tashima T, Takeshita I, Barry RA, DeArmond SJ, Prusiner SB (1986) Amyloid plaques in Creutzfeldt-Jakob disease stain with prion protein antibodies. Ann Neurol 20: 204–208
Klatzo I, Gajdusek DC, Zigas V (1959) Pathology of the kuru. Lab Invest 8: 799–847
Koch TK, Berg BO, De Armond SJ, Gravina RF (1985) Creutzfeldt-Jakob disease in a young adult with idiopathic hypopituitarism. Possible relation to the administration of cadaveric human growth hormone. N Engl J Med 313: 731–733
Kondo K, Kuroiwa Y (1982) A case control study of Creutzfeldt-Jakob disease: association with physical injuries. Ann Neurol 11: 377–381
Kretzschmar HA, Honold G, Seitelberger F, Feucht M, Wessely P, Mehraein P, Budka H (1991) Prion protein mutation in family first reported by Gerstmann, Sträussler, and Scheinker. Lancet 337: 1160
Kretzschmar HA, Kitamoto T, Doerr-Schott J, Mehraein P, Tateishi J (1991) Diffuse deposition of immunohistochemically labeled prion protein in the granular layer of the cerebellum in a patient with Creutzfeldt-Jakob disease. Acta Neuropathol (Berl) 82: 536–540
Kretzschmar HA, Kufer P, Riethmüller G, DeArmond SJ, Prusiner SB, Schiffer D (1992) Prion protein mutation at codon 102 in an Italian family with GerstmannSträussler-Scheinker syndrome. Neurology 42: 809–810
Kretzschmar HA, Prusiner SB, Stowring LE, DeArmond SJ (1986) Scrapie prion proteins are synthesized in neurons. Am J Pathol 122: 1–5
Kretzschmar HA, Stowring LE, Westaway D, Stubblebine WH, Prusiner SB, DeArmond SJ (1986) Molecular cloning of a human prion protein cDNA. DNA 5: 315–324
Krüger H, Meesmann C, Rohrbach E, Müller J, Mertens HG (1990) Panencephalopathic type of Creutzfeldt-Jakob disease with primary extensive involvement of white matter. Eur Neurol 30: 115–119
Kuroiwa Y, Celesia GG (1980) Clinical significance of periodic EEG patterns. Arch Neurol 37: 15–20
Lantos PL (1992) From slow virus to prion: a review of transmissible spongiform encephalopathies. Histopathology 20: 1–11
Laplanche JL, Chatelain J, Launay JM, Gazengel C, Vidaud M (1990) Deletion in prion protein gene in a Moroccan family. Nucleic Acids Res 18: 6745–6746
Laszlo L, Lowe J, Self T, Kenward N, Landon M, McBride T, Farquhar C, McConnell I, Brown J, Hope J, Mayer RJ (1992) Lysosomes as key organelles in the pathogenesis of prion encephalopathies. J Pathol 166: 333–341
Liberski PP, Budka H, Sluga E, Barcikowska M, Kwiecinski H (1991) Tubulovesicular structures in human and experimental Creutzfeldt-Jakob disease. Eur J Epidemiol 7: 551–555
Liberski PP, Budka H, Sluga E, Barcikowska M, Kwiecinski H (1992) Tubulovesicular structures in Creutzfeldt-Jakob disease. Acta Neuropathol (Berl) 84: 238–243
Liberski PP, Kwiecinski H, Barcikowska M, Mirecka B, Kulczycki J, Kida E, Brown P, Gajdusek DC (1991) PrP amyloid plaques in Creutzfeldt-Jakob disease of short duration: immunohistochemical studies of 5 cases from Poland. Eur J Epidemiol 7: 505–510
Liberski PP, Yanagihara R, Gibbs Jr CJ, Gajdusek DC (1990) Appearance of tubulovesicular structures in experimental Creutzfeldt-Jakob disease and scrapie precedes the onset of clinical disease. Acta Neuropathol (Berl) 79: 349–354
Lo Russo F, Neri G, Figa Talamanca L (1980) Creutzfeldt-Jakob disease and sheep brain. A report from central and southern Italy. Ital J Neurol Sci 1: 171–174
Mackenzie A (1983) Immunohistochemical demonstration of glial fibrillary acidic protein in scrapie. J Comp Pathol 93: 251–259
Manaka H, Kato T, Kurita K, Katagiri T, Shikama Y, Kujirai K, Kawanami T, Suzuki Y, Nihei K, Sasaki H, Yamada S, Hirota K, Kusaka H, Imai T (1992) Marked increase in cerebrospinal fluid ubiquitin in Creutzfeldt-Jakob disease. Neurosci Lett 139: 47–49
Mancardi GL, Mandybur TI, Liwnicz BH (1982) Spongiform-like changes in Alzheimer’s disease. An ultrastructural study. Acta Neuropathol (Berl) 56: 146–150
Manson J, West JD, Thomson V, McBride P, Kaufman MH, Hope J (1992) The prion protein gene: a role in mouse embryogenesis? Development 115: 117–122
Markus HS, Duchen LW, Parkin EM, Kurtz AB, Jacobs HS, Costa DC, Harrison MJ (1992) Creutzfeldt-Jakob disease in recipients of human growth hormone in the United Kingdom: a clinical and radiographic study. Q J Med 82: 43–51
Marsh RF, Sipe JC, Morse SS, Hanson RP (1976) Transmissible mink encephalopathy. Reduced spongiform degeneration in aged mink of the Chediak-Higashi genotype. Lab Invest 34: 381–386
Marzewski DJ, Towfighi J, Harrington MG, Merril CR, Brown P (1988) CreutzfeldtJakob disease following pituitary-derived human growth hormone therapy: a new American case. Neurology 38: 1131–1133
Masters CL, Beyreuther K (1988) Neuropathology of unconventional virus infections: molecular pathology of spongiform change and amyloid plaque deposition. In: Novel infectious agents and the central nervous system. Ciba Foundation Symposium 135. Wiley, Chichester, pp 24–36
Masters CL, Gajdusek DC (1982) Rec Adv Neuropathol 2: 139–163
Masters CL, Gajdusek DC, Gibbs Jr CJ (1981) The familial occurrence of Creutzfeldt-Jakob disease and Alzheimer’s disease. Brain 104: 535–558
Masters CL, Gajdusek DC, Gibbs Jr CJ (1981) Creutzfeldt-Jakob disease virus isolations from the Gerstmann-Sträussler syndrome. With an analysis of the various forms of amyloid plaque deposition in the virus-induced spongiform encephalopathies. Brain 104: 559–588
Masters CL, Harris JO, Gajdusek DC, Gibbs Jr CJ, Bernoulli C, Asher DM (1979) Creutzfeldt-Jakob disease: patterns of worldwide occurrence and the significance of familial and sporadic clustering. Ann Neurol 5: 177–188
Masters CL, Richardson Jr EP (1978) Subacute spongiform encephalopathy (Creutzfeldt-Jakob disease). The nature and progression of spongiform change. Brain 101: 333–344
Masullo C, Pocchiari M, Macchi G, Alema G, Piazza G, Panzera MA (1989) Transmission of Creutzfeldt-Jakob disease by dural cadaveric graft. J Neurosurg 71: 954–955
Matthews WB (1975) The clinical aspects of slow virus infections of the human brain. In: Illis LS (ed) Viral diseases of the central nervous system. Baillière Tindall, London, pp 145–160
McKinley MP, Meyer RK, Kenaga L, Rahbar F, Cotter R, Serban A, Prusiner SB (1991) Scrapie prion rod formation in vitro requires both detergent extraction and limited proteolysis. J Virol 65: 1340–1351
McKinley MP, Taraboulos A, Kenaga L, Serban D, Stieber A, DeArmond SJ, Prusiner SB, Gonatas N (1991) Ultrastructural localization of scrapie prion proteins in cytoplasmic vesicles of infected cultured cells. Lab Invest 65: 622–630
Medori R, Montagna P, Tritschler HJ, LeBlanc A, Cortelli P, Tinuper P, Lugaresi E, Gambetti P (1992) Fatal familial insomnia: a second kindred with mutation of prion protein gene at codon 178. Neurology 42: 669–670
Medori R, Tritschler H-J, LeBlanc A, Villare F, Manetto V, Chen HY, Xue R, Leal S, Montagna P, Cortelli P, Tinuper P, Avoni P, Moghi M, Baruzzi A, Hauw JJ, Ott J, Lugaresi E, Autilio-Gambetti L, Gambetti P (1992) Fatal familial insomnia, a prion disease with a mutation at codon 178 of the prion protein gene. N Engl J Med 326: 444–449
Meyer N, Rosenbaum V, Schmidt B, Gilles K, Mirenda C, Groth D, Prusiner SB, Riesner D (1991) Search for a putative scrapie genome in purified prion fractions reveals a paucity of nucleic acids. J Gen Virol 72: 37–50
Miyashita K, Inuzuka T, Kondo H, Saito Y, Fujita N, Matsubara N, Tanaka R, Hinokuma K, Ikuta F, Miyatake T (1991) Creutzfeldt-Jakob disease in a patient with a cadaveric dural graft. Neurology 41: 940–941
Miyazono M, Kitamoto T, Iwaki T, Tateishi J (1992) Colocalization of prion protein and ß protein in the same amyloid plaques in patients with GerstmannSträussler syndrome. Acta Neuropathol (Berl) 83: 333–339
Mizutani T (1981) Neuropathology of Creutzfeldt-Jakob disease in Japan. With special reference to the panencephalopathic type. Acta Pathol Jpn 31: 903–922
Mizutani T, Morimatsu Y, Shiraki H (1984) Clinical pictures of Creutzfeldt-Jakob disease based on 97 autopsy cases in Japan — with special reference to clinicopathological correlation of cerebellar symptoms. Rinsho Shinkei-gaku (Clin Neurol) 24: 23–32
Nakazato Y, Hirato J, Ishida Y, Hoshi S, Hasegawa M, Fukuda T (1990) Swollen cortical neurons in Creutzfeldt-Jakob disease contain a phosphorylated neurofilament epitope. J Neuropathol Exp Neurol 49: 197–205
Nevin S, McMenemey WH, Behrman D, Jones DP (1960) Subacute spongiform encephalopathy — a subacute form of encephalopathy attributable to vascular dysfunction (spongiform cerebral atrophy). Brain 83: 519–564
New MI, Brown P, Temeck JW, Owens C, Hedley-Whyte ET, Richardson EP (1988) Preclinical Creutzfeldt-Jakob disease discovered at autopsy in a human growth hormone recipient. Neurology 38: 1133–1134
Nisbet TJ, MacDonaldson I, Bishara SN (1989) Creutzfeldt-Jakob disease in a second patient who received a cadaveric dura mater graft. JAMA 261: 1118
Nochlin D, Sumi SM, Bird TD, Snow AD, Leventhal CM, Beyreuther K, Masters CL (1989) Familial dementia with PrP-positive amyloid plaques: a variant of Gerstmann-Sträussler syndrome. Neurology 39: 910–918
Oesch B, Westaway D, Wälchli M, McKinley MP, Kent SBH, Aebersold R, Barry RA, Tempst P, Teplow DB, Hood LE, Prusiner SB, Weissmann C (1985) A cellular gene encodes scrapie PrP 27–30 protein. Cell 40: 735–746
Owen F, Poulter M, Collinge J, Leach M, Shah T, Lofthouse R, Chen Y, Crow TJ, Harding AE, Hardy J, Rossor MN (1991) Insertions in the prion protein gene in atypical dementias. Exp Neurol 112: 240–242
Owen F, Poulter M, Lofthouse R, Collinge J, Crow TJ, Risby D, Baker HF, Ridley RM, Hsiao K, Prusiner SB (1989) Insertion in prion protein gene in familial Creutzfeldt-Jakob disease. Lancet 1: 51–52
Palmer MS, Dryden AJ, Hughes JT, Collinge J (1991) Homozygous prion protein genotype predisposes to spoardic Creutzfeldt-Jakob disease. Nature 352: 340–342
Piccardo P, Safar J, Ceroni M, Gajdusek DC, Gibbs Jr CJ (1990) Immunohistochemical localization of prion protein in spongiform encephalopathies and normal brain tissue. Neurology 40: 518–522
Pocchiari M, Masullo C, Salvatore M, Genuardi M, Galgani S (1992) CreutzfeldtJakob disease after non-commercial dura mater graft. Lancet 340: 614–615
Powell-Jackson J, Weller RO, Kennedy P, Preece MA, Whitcombe EM, NewsonDavis J (1985) Creutzfeldt-Jakob disease after administration of human growth hormone. Lancet 2: 244–246
Prusiner SB (1982) Novel proteinaceous infectious particles cause scrapie. Science 216: 136–144
Prusiner SB (1991) Molecular biology of prion diseases. Science 252: 1515–1522
Prusiner SB, Hsiao KK, Bredesen DE, Kingsbury DT (1989) Human slow infections caused by prions. In: Gilden DH, Lipton HL (eds) Clinical and molecular aspects of neurotropic virus infection. Kluwer, Dortrecht, pp 423–467
Prusiner SB, Scott M, Foster D, Pan K-M, Groth D, Mirenda C, Torchia M, Yang S-L, Serban D, Carlson GA, Hoppe PC, Westaway D, DeArmond SJ (1990) Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication. Cell 63: 673–686
Puckett C, Concannon P, Casey C, Hood L (1991) Genomic structure of the human prion protein gene. Am J Hum Genet 49: 320–329
Renault F, Richard P (1991) Early electroretinogram alterations in CreutzfeldtJakob disease after growth hormone treatment. Lancet 338: 191
Roos R, Gajdusek DC, Gibbs CJ (1973) The clinical characteristics of transmissible Creutzfeldt-Jakob disease. Brain 96: 1–20
Salazar AM, Masters CL, Gajdusek DC, Gibbs Jr CJ (1983) Syndromes of amyotrophic lateral sclerosis and dementia: relation to transmissible CreutzfeldtJakob disease. Ann Neurol 14: 17–26
Seitelberger F (1962) Eigenartige familiär-hereditäre Krankheit des Zentralnervensystems in einer niederösterreichischen Sippe. Wien Klin Wochenschr 74: 687–691
Seitelberger F (1981) Spinocerebellar ataxia with dementia and plaque-like deposits. In: Vinken PJ, Bruyn GW (eds) Handbook of clinical neurology, vol 42. North-Holland, Amsterdam, pp 182–183
Seitelberger F (1981) Sträussler’s disease. Acta Neuropathol (Berl) [Suppl] 7: 341–343
Serban D, Taraboulos A, DeArmond SJ, Prusiner SB (1990) Rapid detection of Creutzfeldt-Jakob disease and scrapie prion proteins. Neurology 40: 110–117
Smith TW, Anwer U, DeGirolami U, Drachman DA (1987) Vacuolar change in Alzheimer’s disease. Arch Neurol 44: 1225–1228
Sparkes RS, Simon M, Cohn VH, Fournier REK, Lem J, Klisak I, Heinzmann C, Blatt C, Lucero M, Mohandas T, DeArmond SJ, Westaway D, Prusiner SB, Weiner LP (1986) Assignment of the human and mouse prion protein genes to homologous chromosomes. Proc Natl Acad Sci USA 83: 7358–7362
Spielmeyer W (1922) Histopathologie des Nervensystems. Springer, Berl in Heidelberg
Spielmeyer W (1922) Die histopathologische Forschung in der Psychiatrie. Wien Klin Wochenschr 1: 1817–1819
Stahl N, Borchelt DR, Prusiner SB (1990) Differential release of celllar and scrapie prion proteins from ceullular membranes by phosphatidylinositol-specific phospholipase C. Biochemistry 29: 5405–5412
Steiner I, Polachek I, Melamed E (1984) Dementia and myoclonus in a case of cryptococcal encephalitis. Arch Neurol 41: 216–217
Tagliavini F, Prelli F, Ghiso J, Bugiani O, Serban D, Prusiner SB, Farlow MR, Ghetti B, Frangione B (1991) Amyloid protein of Gerstmann-Sträussler-Scheinker disease (Indiana kindred) is an 11 kd fragment of prion protein with an N-terminal glycine at codon 58. EMBO J 10: 513–519
Taraboulos A, Jendroska K, Serban D, Yang S-L, DeArmond SJ, Prusiner SB (1992) Regional mapping of prion proteins in brain. Proc Natl Acad Sci USA 89: 7620–7624
Taraboulos A, Serban D, Prusiner SB (1990) Scrapie prion proteins accumulate in the cytoplasm of persistently infected cultured cells. J Cell Biol 110: 2117–2132
Tateishi J, Doh-ura K, Kitamoto T, Tranchant C, Warter MM, Boellaard JW (1992) Prion protein gene analysis and transmission studies of Creutzfeldt-Jakob disease. Ellis Horwood (Abstract )
Tateishi J, Tashima T, Kitamoto T (1991) Practical methods for chemical inactivation of Creutzfeldt-Jakob disease pathogen. Microbiol Immunol 35: 163–166
Thadani V, Penar PL, Partington J, Kalb R, Janssen R, Schonberger LB, Rabkin CS, Prichard JW (1988) Creutzfeldt-Jakob disease probably acquired from a cadaveric dura mater graft. Case report. J Neurosurg 69: 766–769
Tintner R, Brown P, Hedley-Whyte ET, Rappaport EB, Piccardo CP, Gajdusek DC (1986) Neuropathologic verification of Creutzfeldt-Jakob disease in the exhumed American recipient of human pituitary growth hormone: epidemiologic and pathogenetic implications. Neurology 36: 932–936
Tranchant C, Doh-ura K, Steinmetz G, Chevalier Y, Kitamoto T, Tateishi J, Warter JM (1991) Mutation of codon 117 of the prion gene in a family of Gerstmann-Sträussler-Scheinker disease. Rev Neurol (Paris) 147: 274–278
Traub RD, Pedley TA (1981) Virus-induced electrotonic coupling: hypothesis on the mechanism of periodic EEG discharges in Creutzfeldt-Jakob disease. Ann Neurol 10: 405–410
Tsuji S, Kuroiwa Y (1983) Creutzfeldt-Jakob disease in Japan. Neurology 33: 1503–1506
Watson CP (1979) Clinical similarity of Alzheimer and Creutzfeldt-Jakob disease. Ann Neurol 6: 368–369
Weissmann C (1991) A “unified theory” of prion propagation. Nature 352: 679–683
Wietgrefe S, Zupancic M, Haase A, Chesebro B, Race R, Frey II W, Rustan T, Friedman RL (1985) Cloning of a gene whose expression is increased in scrapie and in senile plaques in human brain. Science 230: 1177–1179
Will RG, Matthews WB (1982) Evidence for case-to-case transmission of Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 45: 235–238
Will RG, Matthews WB (1984) A retrospective study of Creutzfeldt-Jakob disease in England and Wales 1970–79. I: Clinical features. J Neurol Neurosurg Psychiatry 47: 134–140
Willison HJ, Gale AN, McLaughlin JE (1991) Creutzfeldt-Jakob disease following cadaveric dura mater graft. J Neurol Neurosurg Psychiatry 54: 940
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer-Verlag
About this paper
Cite this paper
Kretzschmar, H.A. (1993). Human prion diseases (spongiform encephalopathies). In: Kaaden, OR., Eichhorn, W., Czerny, CP. (eds) Unconventional Agents and Unclassified Viruses. Archives of Virology, vol 7. Springer, Vienna. https://doi.org/10.1007/978-3-7091-9300-6_21
Download citation
DOI: https://doi.org/10.1007/978-3-7091-9300-6_21
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-82480-1
Online ISBN: 978-3-7091-9300-6
eBook Packages: Springer Book Archive